BLFS — BIOLIFE SOLUTIONS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 834365 ·
Last close
$31.28
Market Cap
$1.53B
52W High
$33.14
52W Low
$20.27
ADV30
1,566,310
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 27,500,000 | 17,496,000 | 27,000 | 1,186,000 | 400,906,000 | 22,822,000 | 28,676,000 |
| Dec 2025 | 18,785,000 | 11,977,000 | 1,347,000 | 11,070,000 | 405,884,000 | 33,038,000 | 33,996,000 |
| Sep 2025 | 28,067,000 | 17,921,000 | -89,000 | 621,000 | 392,081,000 | 29,481,000 | 38,342,000 |
| Jun 2025 | 25,421,000 | 16,433,000 | -16,643,000 | -15,838,000 | 387,240,000 | 31,902,000 | 40,085,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$20,115,000
Investing CF
$-71,539,000
Financing CF
$-10,924,000
CapEx
$-19,699,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.11
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-339,696,000
Inventory
$30,155,000
Receivables
$7,953,000
ST Investments
$55,889,000
EBIT TTM
$-16,603,000
Pretax Income TTM
$-12,081,000
Interest Exp TTM
$267,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$101,660,000
EBITDA
$4,321,000
Free Cash Flow
$6,391,125
Enterprise Value
$1,462,120,960
Total Cash
$80,996,000
Total Debt
$14,857,000
Shares Out
48,857,415
Trailing EPS
$-0.24
Book Value
$7.62
ROE
-3.1%
ROA
-0.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 96,214,000 | -16,602,000 | -4,595,000 | 405,884,000 | 33,996,000 | — | 20,115,000 |
| Dec 2024 | 74,647,000 | -4,477,000 | -20,184,000 | 399,487,000 | 50,578,000 | — | 8,431,000 |
| Dec 2023 | 68,016,000 | -19,398,000 | -68,002,000 | 412,714,000 | 75,051,000 | — | -12,498,000 |
| Dec 2022 | 76,239,000 | -10,677,000 | -139,805,000 | 450,229,000 | 86,041,000 | — | -8,488,000 |
TTM Snapshot
Revenues TTM
$19,715,000
NetIncome TTM
$-20,719,000
OpCashFlow TTM
$0
Assets (Latest)
$399,487,000
Forward EPS
$0.33
Max Pain — expiry 2026-08-21
max pain strike: $25.00 · spot: $31.28 · call oi: 1,099 · put oi: 337Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | $1.46B | $9.52 | — |
| INSP | Inspire Medical Systems, Inc. | $1.45B | $50.21 | — |
| ENOV | Enovis CORP | $1.68B | $29.15 | — |
| CNMD | CONMED Corp | $1.39B | $46.30 | — |
| NVCR | NovoCure Ltd | $1.73B | $14.84 | — |
News headlines (Yahoo Finance, 1h cache)
Repligen (RGEN) Held An M&A Call With BioLife Solutions.
2026-07-28 20:12 · Yahoo
Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance
2026-07-28 14:05 · Yahoo
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
2026-07-23 15:36 · Yahoo
Sector Update: Healthcare Stocks Softer Late Afternoon
2026-07-22 19:48 · Yahoo
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
2026-07-22 19:03 · Yahoo
Top Midday Stories: Trump Threatens Retaliation for Attacks in Strait of Hormuz; AMD to Supply MI450 GPUs to Anthropic
2026-07-22 15:52 · Yahoo
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
2026-07-22 10:00 · Yahoo
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?
2026-06-18 13:54 · Yahoo
BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value
2026-06-04 11:38 · Yahoo
Orthofix Medical and 5 More Stocks See Action From Activist Investors
2026-05-29 21:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.